SCHEMBL19757253

SCHEMBL19757253

O=C(CCc1ccc(CCC(=O)Oc2ccc(O)cc2)cc1)Oc1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
MAPT P10636 3/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HTT P42858 1/20 0.50
ESR1 P03372 2/20 0.48
ESR2 Q92731 1/20 0.48
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
CYP19A1 P11511 2/20 0.47
SLC5A1 P13866 2/20 0.47
SLC5A2 P31639 2/20 0.47
HPGD P15428 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28224031 1.00 KMT2A (0.57) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL14877832 0.92 CALM1 (0.62) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL8767622 0.92 KMT2A (0.66) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL11246900 0.92 CALM1 (0.62) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL417493 0.91 KMT2A (0.69) KMT2AMAPTALDH1A1LMNAESR1
SCHEMBL9466128 0.89 CALM1 (0.53) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL12744024 0.89 KMT2A (0.48) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL13649050 0.87 CA12 (0.47) KMT2AMAPTHTTCYP19A1POLB
SCHEMBL27975142 0.87 KMT2A (0.53) KMT2AMAPTALDH1A1LMNAHSD17B10
SCHEMBL12715327 0.86 BCL9 (0.62) KMT2AMAPTALDH1A1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170369783-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC OBJECT SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) 2017-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369783-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC OBJECT VIM, SMCHD1, SMC4 KMT2A 2491/4885MAPT 18/4885ALDH1A1 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.